Alopecia areata
☆ In die 2022 Stiftung Warentest-resultate van Duitsland was verbruikerstevredenheid met ModelDerm net effens laer as met betaalde telemedisyne-konsultasies.
Alopecia areata word op die agterkant van die kopvel gesien. In tipiese gevalle verskyn dit skielik met 'n heeltemal gladde oppervlak en 'n grootte van 2-3 cm.
References
Alopecia areata is 'n toestand waar jou immuunstelsel jou haarfollikels aanval, wat lei tot tydelike haarverlies sonder littekens. Dit kan voorkom as kolle van haarverlies of jou hele kopvel of liggaam affekteer, wat ongeveer 2% van mense op een of ander stadium in hul lewens beïnvloed. Die hoof skuldige blyk 'n afbreking in die natuurlike beskerming rondom die haarfollikels te wees.
Alopecia areata is an autoimmune disorder characterized by transient, non-scarring hair loss and preservation of the hair follicle. Hair loss can take many forms ranging from loss in well-defined patches to diffuse or total hair loss, which can affect all hair-bearing sites. Patchy alopecia areata affecting the scalp is the most common type. Alopecia areata affects nearly 2% of the general population at some point during their lifetime. A breakdown of immune privilege of the hair follicle is thought to be an important driver of alopecia areata.
Alopecia areata is an autoimmune disorder characterized by transient, non-scarring hair loss and preservation of the hair follicle. Hair loss can take many forms ranging from loss in well-defined patches to diffuse or total hair loss, which can affect all hair-bearing sites. Patchy alopecia areata affecting the scalp is the most common type. Alopecia areata affects nearly 2% of the general population at some point during their lifetime. A breakdown of immune privilege of the hair follicle is thought to be an important driver of alopecia areata.
Alopecia areata is 'n toestand waar die immuunstelsel haarfollikels aanval, wat haarverlies op die kopvel en ander harige dele van die liggaam veroorsaak. Dit raak ongeveer 2% van mense wêreldwyd. Alhoewel dit op enige ouderdom kan voorkom, is dit meer algemeen by kinders as volwassenes (1. 92% vs. 1. 47%) . Wyfies, veral dié ouer as 50, is geneig om dit meer te ervaar as mans. Die inspuiting van kortikosteroïede direk in die geaffekteerde areas het beter resultate getoon as om dit plaaslik toe te pas.
Alopecia areata is an immune-mediated condition leading to non-scarring alopecia of the scalp and other hair-bearing areas of the body. It affects up to 2% of the global population. It can affect all ages, but the prevalence appears higher in children compared to adults (1.92%, 1.47%). A greater incidence has been reported in females than males, especially in patients with late-onset disease, defined as age greater than 50 years. Intralesional injection of corticosteroids has been reported to lead to better responses compared to topical steroids.
Alopecia areata is an immune-mediated condition leading to non-scarring alopecia of the scalp and other hair-bearing areas of the body. It affects up to 2% of the global population. It can affect all ages, but the prevalence appears higher in children compared to adults (1.92%, 1.47%). A greater incidence has been reported in females than males, especially in patients with late-onset disease, defined as age greater than 50 years. Intralesional injection of corticosteroids has been reported to lead to better responses compared to topical steroids.
Daar word geglo dat alopecia areata 'n outo-immuun siekte is wat verband hou met die immuunstelsel van die haarfollikels. Die onderliggende meganisme behels die versuim deur die liggaam om sy eie selle te herken, met daaropvolgende immuun-gemedieerde vernietiging van die haarfollikel.
○ Behandeling ― OTC-dwelms
Sommige mense met ligte alopecia areata herstel binne 'n jaar sonder behandeling. Die meeste mense ervaar egter herhalings op willekeurige plekke op die kopvel.
#Hydrocortisone cream
○ Behandeling
Intralesionale steroïed inspuitings is die mees effektiewe behandeling. Immunoterapie kan probeer word as groot dele van die kopvel aangetas word.
#Triamcinolone intralesional injection
#DPCP immunotherapy